Quarterly Result14 May 2026, 04:51 pm
Biogen Pharmachem: FY26 Revenue ₹255.8 Lakhs, Net Loss ₹35.88 Lakhs
AI Summary
Biogen Pharmachem Industries Ltd approved the audited financial results for the year ended March 31, 2026. The company reported total income of ₹255.80 lakhs and a net loss of ₹35.88 lakhs for the year ended March 31, 2026. The auditor's report has an unmodified opinion. The board meeting was held on May 14, 2026, commencing at 04:00 PM and concluding at 04:30 PM.
Key Highlights
- Audited financial results for FY26 approved with unmodified opinion.
- Total Income for FY26 stood at ₹255.80 Lakhs.
- Net Loss after Tax for FY26 reported as ₹35.88 Lakhs.
- Board meeting held on May 14, 2026, to approve results.